e-ESO Podcasts
Een podcast door ESO - European School of Oncology
143 Afleveringen
-
Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review
Gepubliceerd: 2-2-2023 -
Basics of prostate cancer pathology
Gepubliceerd: 26-1-2023 -
Oligometastaic breast cancer
Gepubliceerd: 19-1-2023 -
Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias
Gepubliceerd: 12-1-2023 -
Summary/Review - Reporting Guidelines - CHEERS
Gepubliceerd: 6-12-2022 -
Role of immunotherapy in head and neck cancer
Gepubliceerd: 1-12-2022 -
AYAs with cancer: the right to be forgotten
Gepubliceerd: 24-11-2022 -
Summary/Review - Reporting Guidelines - SQUIRE
Gepubliceerd: 17-11-2022 -
Male breast cancer
Gepubliceerd: 10-11-2022 -
Summary/Review - Reporting Guidelines - SRQR
Gepubliceerd: 3-11-2022 -
Summary/Review - Reporting Guidelines - AGREE
Gepubliceerd: 27-10-2022 -
Breast Cancer: Frequently Asked Questions and Answers
Gepubliceerd: 20-10-2022 -
The role of Medical Physicist in Oncology
Gepubliceerd: 13-10-2022 -
How to approach to breast cancer patient who had not received neoadjuvant chemo and staged T2NO postoperatively?
Gepubliceerd: 6-10-2022 -
Parp inhibitors in ovarian cancer
Gepubliceerd: 29-9-2022 -
Primary endocrine resistant in recurrent locoregional only Breast cancer (role of endocrine therapy)
Gepubliceerd: 22-9-2022 -
Should Prostate Cancer Patients With History of Cardiovascular Events Be Preferentially Treated With Luteinizing Hormone-Releasing Hormone Antagonists?
Gepubliceerd: 15-9-2022 -
The use of Lutetium PSMA as treatment in mCRPC – in what sequence and how to best select patients
Gepubliceerd: 8-9-2022 -
Use of Medical Cannabis in Oncology. Knowledges and attitudes among oncologist and patient.
Gepubliceerd: 1-9-2022 -
Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?
Gepubliceerd: 27-7-2022
e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net